Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas

E-ISSN： 2212-3954|5|1|53-69

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.5, Iss.1, 2010-01, pp. : 53-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of High-Grade Gliomas in the Elderly

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 1, 2014-04 ,pp. : 2-12

Bentham Science Publishers

Access to resources Recommend Favorite

Permanent Iodine-125 Interstitial Radiation Therapy in the Treatment of Non-Glioblastoma multiforme High-Grade Gliomas

Stereotactic and Functional Neurosurgery, Vol. 81, Iss. 1-4, 2004-01 ,pp. : 10-17

Karger

Access to resources Recommend Favorite

Prognostic Relevance of Histomolecular Classification of Diffuse Adult High‐Grade Gliomas with Necrosis

BRAIN PATHOLOGY, Vol. 25, Iss. 4, 2015-07 ,pp. : 418-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

Temozolomide in Patients with High Grade Gliomas

Oncology, Vol. 59, Iss. 3, 2000-10 ,pp. : 181-186

Karger

Access to resources Recommend Favorite